Traci S.

Experience

• 

  Beth Israel Deaconess Medical Center

  Jan 2007 - Jan 2012

  Instructor

  Active in the education of Harvard Medical School students.

• 

  Neurological Consultants

  Jul 2007 - Jul 2009

  Attending Neurologist

  While employed at Neurological Consultants, I participated in multiple Phase III clinical research studies, mostly in the field of multiple sclerosis. In several studies, I was the principal investigator. My involvement included patient screening, patient monitoring, supervision of research staff, and participation in medical meetings. In addition to experience in multiple sclerosis at this center, I had extensive experience in the field of headache. Approximately 40% of my patient population consisted of headache patients. I was also an active member of the American Headache Society and the Headache and Facial Pain subsection of the American Academy of Neurology, which resulted in two publications in the journal Headache. Show less

• 

  Inland Hospital

  Jul 2009 - May 2012

  Attending Neurologist

  I was the sole provider in a busy general neurology private practice affiliated with Inland Hospital. The great majority of my patient population consisted of headache patients and patients with chronic pain conditions. I oversaw a staff of 2-3, including an office manager, patient services representative, and medical assistant. I had significant input regarding budgeting and business planning.

• 

  Teva Pharmaceuticals

  Jun 2012 - Jun 2017

  Multiple Sclerosis MSL, covering Maine, New Hampshire, Eastern Massachusetts / Boston Area, and Rhode Island.As a multiple sclerosis medical science liaison, I acted as a fair and balanced scientific resource to both internal and external stakeholders. I built outstanding relationships with Key Opinion Leaders in the field, both at regional and national levels.I participated in launch activities with Copaxone 40mg/mL TIW, including education of the sales staff and of promotional speakers. Show less

  • Medical Director, Multiple Sclerosis

    Jan 2017 - Jun 2017

  • Associate Medical Director, Neurodegenerative Disorders

    Apr 2015 - Jan 2017

  • Medical Science Liaison

    Jun 2012 - Apr 2015
• 

  Axovant Sciences

  Jun 2017 - Oct 2017

  Field Medical Director, Scientific Lead

  As Field Medical Director, Scientific Lead at Axovant Sciences, I performed essential Medical Affairs functions, both in the field and internally, supporting the Alzheimer's disease and dementia with Lewy bodies programs.

• 

  PTC Therapeutics, Inc.

  Nov 2017 - Dec 2021

  • Executive Director, Gene Therapy Clinical Development

    Jan 2019 - Dec 2021

  • Executive Director, US and Global DMD Lead

    Nov 2017 - Jan 2019
• 

  Eli Lilly and Company

  Dec 2021 - now

  Medical Fellow, Donanemab Medical Affairs